A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors

Abstract Background Liposomes are drug nano-carriers that are capable of targeting therapeutics to tumor sites because of enhanced permeability retention (EPR). In several preclinical studies with various tumor-bearing mice models, 188Re-liposome that has been developed by the Institute of Nuclear E...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shyh-Jen Wang, Wen-Sheng Huang, Chi-Mu Chuang, Chih-Hsien Chang, Te-Wei Lee, Gann Ting, Ming-Huang Chen, Peter Mu-Hsin Chang, Ta-Chung Chao, Hao-Wei Teng, Yee Chao, Yuh-Min Chen, Tzu-Ping Lin, Ya-Jen Chang, Su-Jung Chen, Yuan-Ruei Huang, Keng-Li Lan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SpringerOpen 2019-05-01
coleção:	EJNMMI Research
Assuntos:	188Re Liposome Biodistribution Dosimetry; phase 0 exploratory IND
Acesso em linha:	http://link.springer.com/article/10.1186/s13550-019-0509-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!